Visit the MPX Bioceutical Corporation Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
MPX Bioceutical Announces Beth Stavola Appointed to New Jersey Cannabis Industry Association Board of Trustees
TORONTO, Jan. 03, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) today announced that Beth Stavola, Chief Operating Officer, and a Director of MPX, has been appointed to the Board of Trustees of the New Jersey Cannabis Industry Association (“NJCIA”).
The New Jersey Cannabis Industry Association is dedicated to advancing the legalization of cannabis in the State of New Jersey, through the development of sensible policies that promote responsible growth. The NJCIA is looking to become an industry leader for all sectors involved in cannabis including industrial hemp, biotechnology, cultivation, manufacturing, finance, security and consulting services. The Association will work to educate New Jersey legislators and decision makers and help them to navigate the changing face of the cannabis debate and to provide advice and guidance for the development of a well-regulated and responsible industry. An advisory board only, the NJCIA does not provide approval for licensing applicants
Beth’s appointment to the Board of Trustees at the NJCIA is a reflection of her formidable industry expertise. Her depth of practical and regulatory knowledge garnered through the development of successful cannabis businesses in several states is sure to prove invaluable to the Board as it looks to facilitate the development of New Jersey’s burgeoning cannabis industry.
Scott Boyes, Chairman, President and CEO of MPX
“I look forward to working with the Board of the NJCIA to help bring cannabis best practices to the State of New Jersey,“ said Beth Stavola. “Building a strong framework based on sound policies will help promote responsible development and generate sustainable economic growth.”
About MPX Bioceutical Corporation
MPX, an Ontario corporation, through its wholly owned subsidiaries in the U.S., provides substantial management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona operating under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. The successful Health for Life brand operates in the rapidly growing Phoenix Metropolitan Statistical Area.
The recently acquired GreenMart of Nevada NLV, LLC (“GreenMart”) is an award winning licensed cultivation, production and wholesale business, licensed for both the medical and “adult use” sectors in Las Vegas, Nevada, and is already selling wholesale into the Nevada medical cannabis market. GreenMart has also optioned suitable locations and intends to enter the higher-margin retail arena by applying for at least two dispensary licenses in the Las Vegas market which will operate under the “Health for Life” brand.
The Company owns assets in Massachusetts supporting cultivation, production and up to three dispensaries there, and with the closing of this most recent transaction, MPX has added the management of a full-service dispensary in Maryland.
MPX continues to expand its U.S. footprint, and is in the process of acquiring management companies that provide operational and other services to two further dispensaries and one production license in Maryland. The Company also leases a property in Owen Sound, Ontario, for which an application to Health Canada has been made for a cannabis production and sales license. In addition, the Company will continue its efforts to develop its legacy nutraceuticals business.
The most reliable, fact-based information on MPX Bioceutical Corp found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.